Buy Ujvira Trastuzumab Emtansine 160 mg Injection Online – GlobMedIndia India.

Ujvira Trastuzumab Emtansine 160 mg Injection

Ujvira Trastuzumab Emtansine 160 mg Injection is an advanced targeted anti-cancer medication used primarily in the treatment of HER2-positive breast cancer. It is an antibody-drug conjugate (ADC), which combines the targeted action of trastuzumab with a powerful chemotherapy agent (emtansine), delivering the drug directly to cancer cells while minimizing damage to healthy tissues.

Introduction

Ujvira Trastuzumab Emtansine 160 mg Injection is prescribed for patients with HER2-positive metastatic or early breast cancer, especially when previous treatments like trastuzumab and taxanes have not been fully effective. It works by targeting HER2 receptors on cancer cells and releasing chemotherapy directly inside them, improving treatment outcomes.

📞 Contact Details to Place Order

💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
🌐 Website: https://globmedindia.com

Composition and Content

Active Ingredient: Trastuzumab Emtansine (160 mg)
Form: Lyophilized powder for injection
Class: Antibody-Drug Conjugate (ADC)
Combines:
- Trastuzumab – Monoclonal antibody targeting HER2 receptors
- DM1 (Emtansine) – Cytotoxic agent that destroys cancer cells

How to Use

Administered intravenously (IV infusion) under medical supervision
Given in a hospital or oncology clinic
Infusion duration typically 30–90 minutes
Not for self-administration

Dosage

Standard dose: 3.6 mg/kg body weight
Administered once every 3 weeks (21-day cycle)
Dose adjustments may be required based on:
- Liver function
- Side effects
- Patient tolerance

Uses

HER2-positive metastatic breast cancer
Adjuvant treatment in early HER2-positive breast cancer
Patients who have previously received trastuzumab-based therapy

Treatment Benefits

Targeted therapy with higher precision
Reduces damage to healthy cells
Effective in resistant or advanced cancer cases
Improves progression-free survival

Advantages

Dual mechanism: targeted + chemotherapy
Fewer systemic side effects compared to traditional chemo
Convenient 3-week dosing schedule
Proven efficacy in HER2-positive patients

Storage Conditions

Store at 2°C to 8°C (refrigerated)
Do not freeze
Protect from light
Use immediately after reconstitution or as directed

Alternative Indian Brands

Some commonly available alternatives to Ujvira include:

Kadcyla (Trastuzumab Emtansine) – by Roche
Biceltis / other biosimilars (availability may vary in India)

(Always consult an oncologist before switching brands.)